GlassScriptPhysician profile
Gabriel Herscu
NPI 1528230679
$6,927.64
in general payments reported to CMS, 2019-2025
17 companies · $1,929 in 2025
The $1,929 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,881 · 2020: $925 · 2021: $185 · 2022: $162 · 2023: $613 · 2024: $232 · 2025: $1,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,487 · Travel and Lodging: $1,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,486.85 |
| Travel and Lodging | $1,287.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,136.01 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Nuvasive, INC. | $1,285.85 | 2019 | |
| Silk Road Medical, INC. | $873.40 | 2020 | |
| Boston Scientific Corporation | $798.43 | 2022-2025 | General - Vascular Intervention, Ranger, Jetstream Sc |
| Medtronic, INC. | $261.58 | 2025 | Endurant Iis, Venaseal |
| Smith+Nephew, INC. | $156.19 | 2021-2024 | Regranex, Collagenase Santyl |
| Biotronik INC. | $90.15 | 2023 | Passeo-18 |
| Kerecis Limited | $63.02 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Livanova USA, INC. | $52.16 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Zimmer Biomet Holdings, INC. | $37.95 | 2023 | |
| Mimedx Group, INC. | $37.38 | 2024 | |
| Bard Peripheral Vascular, INC. | $35.00 | 2019 | |
| Merck Sharp & Dohme LLC | $33.78 | 2023-2024 | Bridion |
| Venclose INC. | $17.75 | 2020 | |
| Neurocrine Biosciences, INC. | $16.73 | 2024 | Ingrezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $16.16 | 2023 | Prevena, V.A.C. Veraflo |
| Inari Medical, INC. | $16.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Herscu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.